Description
Pal-GHK (Palmitoyl Tripeptide-1) and Pal-GQPR (Palmitoyl Tetrapeptide-7), also known as Matrixyl 3000, are synthetic peptides specifically designed to provide potent anti-aging benefits, stimulating collagen production, improving skin elasticity, and reducing the appearance of fine lines and wrinkles, while also helping to calm and soothe the skin, resulting in a smoother, more youthful, and radiant complexion.
Pal-GHK contains fragments of Collagen and Glycoaminogl (GAG), which are important components of the skin structure. Helps the skin to be firmer.
Pal-GQPR contains a fragment of Immunoglobulin G (lgB), which plays an important role in reducing the production of Interleukin 6 (IL6), which is an important cause of inflammation. and leads to aging of the skin Normally, our body already has an important hormone that helps control IL6 and this inflammatory process, which is DHEA (Dehydroepiandosterone or Youth hormone). But as we get older, The production of this hormone is not enough. Adding Pal-GQPR will help stimulate the production of IgG to act in place of DHEA.
Benefits
1. Anti-Aging: Reduces the appearance of fine lines and wrinkles.
2. Collagen Stimulation: Stimulates collagen production, improving skin elasticity.
3. Skin Smoothing: Helps to smooth out skin texture and reduce wrinkles.
4. Soothing and Calming: Calms and soothes the skin, reducing inflammation.
5. Youthful Appearance: Results in a more youthful, radiant, and smoother complexion.
INCI Name: Glycerin (and) Water (and) Butylene Glycol (and) Carbomer (and) Polysorbate 20 (and) Palmitoyl Oligopeptide (and) Palmitoyl Tetrapeptide-7
Percentage Purity : – 95% to 99%
Color & Appearance: Clear cloudy liquid
Grade: Cosmetic Grade
Country of Origin: China
Packaging: Our water/Oil based ingredients are bottled in plastics avoid spillage.
DISCLAIMER: All SOPHIX NATURAL PRODUCTS are for external use only unless otherwise STATED. This information is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.